india's top companies final(group 1)

8/10/2019 India's Top Companies FINAL(Group 1)

1/32

INDIAS TOP STAR COMPANIES YOU

CAN INVEST IN

COMPILED BY:

FALGUNI,AYON,APOORVA,ABHISHEK,AJAY,DEEPAK,SWAPNIL,AKHIL

& ANKITA *


2/32

*


3/32

STOCK SELECTION CRITERIA

Sector Analysis

Fundamental Analysis

Management Issues

Technical Analysis

*


4/32

MRF


5/32

TRAILING 12 MONTHS EPS


6/32

COMPANY PROFILE

WHO WE ARE

6 interdependent facilities.

3000 strong dealer networks.

180 different offices.

WHAT WE DO

Tyres & Radials

Paints & coats (Polyurethane Coating)

Toys (Funskool)

Motorsports

Conveyor belts and elevator belting

AWARDS

Ford Excellence awards

Most Trusted Tyre company in India

JD Power Award for the 10th time


7/32

RACING AHEAD

Rs. In crore 2004 2009 2013

Net Sales 2989.43 6141.94 13444.75

Profit before

taxation

42.90 398.48 1226.80

Reserves 719.17 1357.18 3640.90

Net Worth 723.41 1361.42 3645.14

NET SALES-

generated after the deduction of returns,allowances for damaged or missing goods and any discounts

RETURN ON SHAREHOLDERS EQUITY - 24.67 at the end of

last financial year


8/32

MRF VENTURED INTO

1.Racing

2.Rallying3.Karting

4.Tyres for Sukhoi

Aircraft


9/32

FUTURE PROSPECTS OF MRF

1.High Margin in

Replacement Sector2.R&D

3.Market Penetration


10/32


11/32

HISTORY

1983Sun Pharma established with five psychiatry products andtwo person marketing team at Vapi, Gujarat.

1991- First research canter established in India.

1994Sun Pharma went public in an issue that was oversubscribed55 times.

1989Exports to neighbouring countries began. 2000Sun Pharma ranked 5thlargest pharmaceutical company in

India.

2007Sun Pharma demerged into a separate entity Sun PharmaAdvanced Research Company, the first research company to get

listed on stock exchanges in India. 1997 to CurrentAcquired many major pharmaceuticals companys

like Dusa pharmaceuticals , Milmet labs and Taro pharmaceuticals.


12/32

BOARD OF DIRECTORS

ChairmanIsrael Makov

Managing DirectorDilip S. Shanghvi

Executive DirectorSudhir V. Valia, SaileshDesai

Non-executive independent director

Hasmukh Shah, Keki M. Mistry, Ashwin Dani,

S. Mohanchand Dadha.


13/32

Challenges and Strengths

Challenges : Patents and Intellectual property rights.

FDI in Indian pharmaceutical sector.

Regulatory Reforms.

Pricing Issues.

Strengths : Financial strength.

Less legal restrictions.

Globalization.

Latest information and technology.

Population.


14/32

Stock Exchange


15/32

Stock Analysis


16/32


17/32

WHY BANKING?


18/32

17000+Branches

5 associate banks

21000+ATMs 180 offices in 34 countries

Top bank in India based on tier 1

capitalby The Bankermagazine in a 2014ranking.

High amount of CASA deposit

Government of India holding 58.6%.
http://en.wikipedia.org/wiki/Tier_1_capitalhttp://en.wikipedia.org/wiki/Tier_1_capitalhttp://en.wikipedia.org/wiki/The_Bankerhttp://en.wikipedia.org/wiki/The_Bankerhttp://en.wikipedia.org/wiki/Tier_1_capitalhttp://en.wikipedia.org/wiki/Tier_1_capital


19/32

Past performance of Stock


20/32

Financial overview of SBI

20


21/32

Todays Stock Price

21


22/32

Growth parameters

22


23/32

Earning Per Share & Cost to Income

Ratio

184.8

168.3

228.6

261.9

0

50

100

150

200

250

300

2010 2011 2012 2013

Earning Per Share (Rs.)

23


24/32

Advantages and Future Prospects

As of December 2013 , SBI has recorded US $ 388 Billion

worth of assets and INR 200,560 Crores worth of revenue.

Government of India holding 58.6%.

With RBI decision of Deregulation of rates on saving bank

account , SBI will be at significant advantage.

Plan to increase its branch network to 50000, by the end of

the current decade.

24


25/32


26/32


27/32


28/32

Financial performance of the

company in last five years Oil and Natural Gas Corporation Ltd ONGC

Income statement in INR

Year on year Oil and Natural Gas Corporation Ltd grew revenues 7.30%

from 1.61tn to 1.73tn while net income improved 9.44% from

242.20bn to 265.07bn.


29/32

Growth rates in INR

Year on year, growth in dividends per share fell 2.63% while earnings

per share excluding extraordinary items rose 9.44%. Additionally when

measured on a five year annualized basis, both dividend per share andearnings per share growth ranked in-line with the industry average

relative to its peers.


30/32


31/32


32/32

CONCLUSION

All eggs should not be kept in a single basket

The key to successful investment is

"PORTFOLIO DIVERSIFICATION"

*

india's top companies final(group 1)

Documents